Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions

DSpace/Manakin Repository

Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions

Citable link to this page

 

 
Title: Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions
Author: Cami, Aurel; Manzi, Shannon; Arnold, Alana; Reis, Ben Y.

Note: Order does not necessarily reflect citation order of authors.

Citation: Cami, Aurel, Shannon Manzi, Alana Arnold, and Ben Y. Reis. 2013. Pharmacointeraction network models predict unknown drug-drug interactions. PLoS ONE 8(4): e61468.
Full Text & Related Files:
Abstract: Drug-drug interactions (DDIs) can lead to serious and potentially lethal adverse events. In recent years, several drugs have been withdrawn from the market due to interaction-related adverse events (AEs). Current methods for detecting DDIs rely on the accumulation of sufficient clinical evidence in the post-market stage – a lengthy process that often takes years, during which time numerous patients may suffer from the adverse effects of the DDI. Detection methods are further hindered by the extremely large combinatoric space of possible drug-drug-AE combinations. There is therefore a practical need for predictive tools that can identify potential DDIs years in advance, enabling drug safety professionals to better prioritize their limited investigative resources and take appropriate regulatory action. To meet this need, we describe Predictive Pharmacointeraction Networks (PPINs) – a novel approach that predicts unknown DDIs by exploiting the network structure of all known DDIs, together with other intrinsic and taxonomic properties of drugs and AEs. We constructed an 856-drug DDI network from a 2009 snapshot of a widely-used drug safety database, and used it to develop PPIN models for predicting future DDIs. We compared the DDIs predicted based solely on these 2009 data, with newly reported DDIs that appeared in a 2012 snapshot of the same database. Using a standard multivariate approach to combine predictors, the PPIN model achieved an AUROC (area under the receiver operating characteristic curve) of 0.81 with a sensitivity of 48% given a specificity of 90%. An analysis of DDIs by severity level revealed that the model was most effective for predicting “contraindicated” DDIs (AUROC = 0.92) and less effective for “minor” DDIs (AUROC = 0.63). These results indicate that network based methods can be useful for predicting unknown drug-drug interactions.
Published Version: doi:10.1371/journal.pone.0061468
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631217/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11180470
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters